title: Impact of acute myocardial infarct location on myocardial salvage after stenting or thrombolysis (results from the STOPAMI 1 and 2 trials): Stent versus Thrombolysis for Occluded coronary arteries in Patients with Acute Myocardial Infarction.
authors.affiliation: Deutsches Herzzentrum and 1. Medizinische Klinik des Klinikums rechts der Isar, Technische Universität, Munich, Germany. hausleiter@dhm.mhn.de
authors.forename: Jörg
authors.initials: J
authors.lastname: Hausleiter
authors.forename: Adnan
authors.initials: A
authors.lastname: Kastrati
authors.forename: Julinda
authors.initials: J
authors.lastname: Mehilli
authors.forename: Helmut
authors.initials: H
authors.lastname: Schühlen
authors.forename: J ürgen
authors.initials: Jü
authors.lastname: Pache J
authors.forename: Josef
authors.initials: J
authors.lastname: Dirschinger
authors.forename: Ullrich
authors.initials: U
authors.lastname: Schricke
authors.forename: Markus
authors.initials: M
authors.lastname: Schwaiger
authors.forename: Christina
authors.initials: C
authors.lastname: Markward
authors.forename: Albert
authors.initials: A
authors.lastname: Schömig
mesh_terms: D000077284:Abciximab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D003327:Coronary Disease / Q000150:complications / Q000628:therapy*; D005260:Female; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000473:pathology / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D016879:Salvage Therapy; D015607:Stents; D015912:Thrombolytic Therapy / Q000379:methods*
chemical_list: D000911:Antibodies, Monoclonal; D000925:Anticoagulants; D007140:Immunoglobulin Fab Fragments; D000077284:Abciximab